Santen Pharmaceutical Co., Ltd.
Notice of Completion of Payment for Disposal of Treasury Shares as Post-Delivery Performance-Linked Stock Compensation
Payment procedures for the disposal of treasury shares as post-delivery performance-linked stock compensation have been completed. The disposed shares totaled 68,912 shares, at 1,867.5 yen per share, amounting to 128,693,158 yen. The shares were allocated among a total of 38 recipients including directors and executive officers. The implementation date was September 30, 2026.
Key Figures
- 68,912 shares
- 1,867.5 yen per share
- Total 128,693,158 yen
AI要約
Completion of Disposal of Treasury Shares under Post-Delivery Performance-Linked Stock Compensation
Santen Pharmaceutical Co., Ltd. announced that the payment procedures for the disposal of treasury shares as post-delivery performance-linked stock compensation based on the board resolution held on September 3, 2026 have been completed. The disposed shares totaled 68,912 shares at 1,867.5 yen per share, for a total of 128,693,158 yen. The shares were disposed to 3 directors (excluding outside directors) and 7 executive officers and allocated to a total of 38 recipients, with the payment date set at September 30, 2026.
Background and Scope
This matter involves disposal of treasury shares as part of the remuneration program centered on directors and executive officers, linked to post-delivery performance-linked stock compensation. The IR note refers to the notice dated September 3, 2026 for details; only this completion report is described in the current document.
Santen Pharmaceutical Co., Ltd.
Company overview · Stock price · Financial data · All IR
